ESC 365 - Monoclonal antibodies, gene silencing, and gene editing (CRISPR) therapies for the treatment of hyperlipidaemia

ESC Professional Premium Access

Monoclonal antibodies, gene silencing, and gene editing (CRISPR) therapies for the treatment of hyperlipidaemia

Session: Revolutionary new cardiovascular disease therapies: future now

Topic: Pharmacology and Pharmacotherapy

Speaker: Professor K. Ray (London, GB)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Professor Kausik K Ray

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)

91 presentations

16 followers

4 more presentations in this session

Genetic therapy to cure the heart: inherited cardiomyopathies

Speaker: Professor H. Watkins (Oxford, GB)

RNA-based therapies for cardiovascular disease

Speaker: Professor S. Zacchigna (Trieste, IT)

RNA interference for treating hypertension

Speaker: Doctor A. Desai (Boston, US)

Revolutionary new cardiovascular disease therapies: future now - discussion

Access the full session

Revolutionary new cardiovascular disease therapies: future now

Speakers: Professor K. Ray, Professor H. Watkins, Professor S. Zacchigna, Doctor A. Desai

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources